Financhill
Sell
40

ADVM Quote, Financials, Valuation and Earnings

Last price:
$2.54
Seasonality move :
-21.58%
Day range:
$2.50 - $2.70
52-week range:
$1.78 - $10.14
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.01x
Volume:
65.8K
Avg. volume:
278.4K
1-year change:
-67.39%
Market cap:
$53.1M
Revenue:
$1M
EPS (TTM):
-$6.40

Earnings Data

Next earnings date for ADVM
Aug 12
2025
Most recent earnings per share
-$2.25
Missed by $0.28
(May 14/2025)
Consensus Estimate
-$1.97
(May 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ADVM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 -- -- -- -$0.92 --
08/12/2025 Q2 -- -- -- -$2.28 --
05/14/2025 Q1 -- -- -$2.25 -$1.97 -$0.28
03/25/2025 Q4 -- -- -$1.96 -$1.39 -$0.58
11/04/2024 Q3 $62.5K $1M -$1.30 -$1.30 $0.00
08/12/2024 Q2 $66.3K -- -$0.89 -$1.47 $0.58
05/09/2024 Q1 $72.9K -- -$1.50 -$1.44 -$0.06
03/18/2024 Q4 -- -- -$2.83 -$3.35 $0.52
11/09/2023 Q3 -- -- -$3.26 -$3.13 -$0.14
08/10/2023 Q2 -- -- -$3.13 -$3.30 $0.17
05/11/2023 Q1 -- $3.6M -$2.90 -- --
03/30/2023 Q4 -- -- -$3.30 -- --
11/10/2022 Q3 -- -- -$4.00 -- --
08/11/2022 Q2 -- -- -$4.40 -- --
05/12/2022 Q1 -- -- -$3.80 -- --
03/29/2022 Q4 -- -- -$3.50 -- --
11/04/2021 Q3 -- -- -$3.90 -- --
08/05/2021 Q2 -- -- -$4.50 -- --
05/06/2021 Q1 -- $7.5M -$2.90 -- --
03/01/2021 Q4 -- -- -$3.90 -- --
11/05/2020 Q3 -- -- -$3.10 -- --
08/10/2020 Q2 -- -- -$3.60 -- --
05/28/2020 Q1 -- -- -$3.10 -- --
03/12/2020 Q4 -- -- -$3.00 -- --
11/07/2019 Q3 -- $250K -$2.50 -- --
08/08/2019 Q2 -- -- -$2.30 -- --
05/08/2019 Q1 -- -- -$2.30 -- --
03/06/2019 Q4 -- $70K -$2.40 -- --
11/08/2018 Q3 -- $833K -$3.40 -- --
08/08/2018 Q2 -- $493K -$3.00 -- --
05/09/2018 Q1 -- $216K -$3.00 -- --
03/06/2018 Q4 -- $461K -$3.20 -- --
11/08/2017 Q3 -- $463K -$3.20 -- --
06/30/2017 Q2 -- $463K -$2.70 -- --
03/31/2017 Q1 -- $462K -$3.80 -- --
12/31/2016 Q4 -- $488K -$5.40 -- --
09/30/2016 Q3 -- $395K -$3.50 -- --
06/30/2016 Q2 -- $307K -$17.60 -- --
03/31/2016 Q1 -- $265K -$5.70 -- --
12/31/2015 Q4 -- $960K -$5.45 -- --
09/30/2015 Q3 -- $953K -$5.50 -- --

Adverum Biotechnologies Earnings Questions

  • How Much did Adverum Biotechnologies Generate in Revenue Last Quarter?

    Adverum Biotechnologies reported -- worth of top line sales in its most recent quarter.

  • Did Adverum Biotechnologies Beat Earnings Last Quarter?

    Adverum Biotechnologies announced earnings per share of -$2.25 which represents a miss of analyst forecast a -$1.97 per share.

  • Is Adverum Biotechnologies Profitable?

    Adverum Biotechnologies reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Adverum Biotechnologies EPS Next Year?

    Adverum Biotechnologies's earnings are forecast to decrease from -$6.62 per share to -$5.04 per share next year representing a decrease of -14.71%.

  • When is Adverum Biotechnologies's Earnings Date?

    Adverum Biotechnologies's next earnings date is August 12, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Is the Ceiling for IONQ Stock?
What Is the Ceiling for IONQ Stock?

IonQ (NYSE:IONQ) is a quantum computing startup that, like many…

Can FUBO Stock Double?
Can FUBO Stock Double?

TV streaming service Fubo (NYSE:FUBO) has seen incredible returns so…

Where Will CoreWeave Stock Be in 1 Year?
Where Will CoreWeave Stock Be in 1 Year?

When CoreWeave (NASDAQ: CRWV) slipped below its $40 IPO price…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 12

MiNK Therapeutics [INKT] is up 727.94% over the past day.

Buy
51
NEGG alert for Jul 12

Newegg Commerce [NEGG] is up 74.03% over the past day.

Buy
68
ATRO alert for Jul 12

Astronics [ATRO] is up 16.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock